Ingmar Hoerr active positions
| Companies | Position | Start | End |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Director/Board Member | - | - |
| Chief Executive Officer | 2020-03-10 | - | |
| Founder | 2010-05-10 | - | |
| Chairman | 2018-06-19 | 2020-03-10 |
Career history of Ingmar Hoerr
Former positions of Ingmar Hoerr
| Companies | Position | Start | End |
|---|---|---|---|
| CUREVAC N.V. | Director/Board Member | 1999-12-31 | 2020-02-29 |
| Chief Executive Officer | 1999-12-31 | 2020-02-29 | |
| Founder | 1999-12-31 | 2020-02-29 |
Training of Ingmar Hoerr
| Donau-Universität Krems | Masters Business Admin |
| Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistics
International
| Germany | 4 |
| Austria | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Private companies | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Stock Market
- Insiders
- Ingmar Hoerr
- Experience
